{"entity":{"type":"insider","cik":"0001823925","url":"/insider/0001823925","json_url":"/insider/0001823925.json","name":"Frohlich Tom","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2021-09-24","last":"2025-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Frohlich Tom","source":"filing","n_filings":10,"first_seen":"2021-09-24","last_seen":"2025-05-19"}],"transactions":[{"id":4835927,"accession":"0000950170-25-074496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-074496","line_url":"/filing/0000950170-25-074496#line-1","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Jade Biosciences, Inc.","issuer_ticker":"JBIO","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":7.4,"price_display":"7.40","price_state":"stated","total_value":44400.0,"total_display":"44,400.00","total_whole":"44,400","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":8462230,"accession":"0001209191-23-009769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-009769","line_url":"/filing/0001209191-23-009769#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":23.7485,"price_display":"23.75","price_state":"stated","total_value":87869.45,"total_display":"87,869.45","total_whole":"87,869","shares_owned_after":150777.0,"shares_owned_after_display":"150,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-15","scope":"insider"},{"id":8605495,"accession":"0001209191-23-006375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-006375","line_url":"/filing/0001209191-23-006375#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4566.0,"shares_display":"4,566","price_per_share":24.6824,"price_display":"24.68","price_state":"stated","total_value":112699.8384,"total_display":"112,699.84","total_whole":"112,700","shares_owned_after":147674.0,"shares_owned_after_display":"147,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":6354428,"accession":"0001209191-22-061442","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-061442","line_url":"/filing/0001209191-22-061442#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.0005,"price_display":"25.00","price_state":"stated","total_value":250005.0,"total_display":"250,005.00","total_whole":"250,005","shares_owned_after":143907.0,"shares_owned_after_display":"143,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-15","scope":"insider"},{"id":6213029,"accession":"0001209191-22-056210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-056210","line_url":"/filing/0001209191-22-056210#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.1642,"price_display":"22.16","price_state":"stated","total_value":221642.0,"total_display":"221,642.00","total_whole":"221,642","shares_owned_after":143907.0,"shares_owned_after_display":"143,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-09","scope":"insider"},{"id":6399224,"accession":"0001209191-22-053304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053304","line_url":"/filing/0001209191-22-053304#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7360.0,"shares_display":"7,360","price_per_share":19.692,"price_display":"19.69","price_state":"stated","total_value":144933.12,"total_display":"144,933.12","total_whole":"144,933","shares_owned_after":143907.0,"shares_owned_after_display":"143,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-11","scope":"insider"},{"id":6120338,"accession":"0001209191-22-009560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-009560","line_url":"/filing/0001209191-22-009560#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3735.0,"shares_display":"3,735","price_per_share":12.7408,"price_display":"12.74","price_state":"stated","total_value":47586.888,"total_display":"47,586.89","total_whole":"47,587","shares_owned_after":137685.0,"shares_owned_after_display":"137,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":4105547,"accession":"0001209191-21-064364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-064364","line_url":"/filing/0001209191-21-064364#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6230.0,"shares_display":"6,230","price_per_share":15.48,"price_display":"15.48","price_state":"stated","total_value":96440.4,"total_display":"96,440.40","total_whole":"96,440","shares_owned_after":134619.0,"shares_owned_after_display":"134,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider"},{"id":4903620,"accession":"0001209191-21-063790","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-063790","line_url":"/filing/0001209191-21-063790#line-4","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13770.0,"shares_display":"13,770","price_per_share":15.1734,"price_display":"15.17","price_state":"stated","total_value":208937.718,"total_display":"208,937.72","total_whole":"208,938","shares_owned_after":140849.0,"shares_owned_after_display":"140,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-09","scope":"insider"},{"id":4903608,"accession":"0001209191-21-063790","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-063790","line_url":"/filing/0001209191-21-063790","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":280000.0,"total_display":"280,000.00","total_whole":"280,000","shares_owned_after":159619.0,"shares_owned_after_display":"159,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-09","scope":"insider","n_lines":2},{"id":4793418,"accession":"0001209191-21-057713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057713","line_url":"/filing/0001209191-21-057713#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823925","owner_name":"Frohlich Tom","owner_display_name":"Frohlich Tom","owner_url":"/insider/0001823925","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":260000.0,"total_display":"260,000.00","total_whole":"260,000","shares_owned_after":133398.0,"shares_owned_after_display":"133,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-24","filed_date":"2021-09-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001798749","name":"Jade Biosciences, Inc.","url":"/issuer/0001798749","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2025-05-19","last_seen":"2025-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"CHINOOK THERAPEUTICS, INC.","url":"/issuer/0001435049","role":"Officer (Chief Operating Officer)","n_filings":9,"first_seen":"2021-09-24","last_seen":"2023-02-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001823925","retrieved_at":"2026-08-23T07:19:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}